Old Web
English
Sign In
Acemap
>
authorDetail
>
Soazig Nénan-Le Ficher
Soazig Nénan-Le Ficher
Medicine
Pathology
Urology
Bladder cancer
Atezolizumab
3
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
NACRE: A randomized study comparing short course radiotherapy with radiochemotherapy for locally advanced rectal cancers in the elderly—Preliminary results.
2021
Journal of Clinical Oncology
Eric Francois
Mandy Pernot
Philippe Ronchin
Elodie Nouhaud
Isabelle Martel-Lafay
Artru Pascal
Pierre Clavère
Véronique Vendrely
Valérie Boige
Brice Thamphya
Soazig Nénan-Le Ficher
Nicolas Magné
Show All
Source
Cite
Save
Citations (3)
Vefora, GETUG-AFU V06 study: Randomized multicenter phase II/III trial of fractionated cisplatin (CI)/gemcitabine (G) or carboplatin (CA)/g in patients (pts) with advanced urothelial cancer (UC) with impaired renal function (IRF)—Results of a planned interim analysis.
2020
Journal of Clinical Oncology
Loic Mourey
Aude Flechon
Diego Tosi
Sophie Abadie Lacourtoisie
Florence Joly
Aline Guillot
Yohann Loriot
Jérôme Dauba
Guilhem Roubaud
Frederic Rolland
Christine Abraham
Hélène Gauthier
Philippe Barthélémy
Gwenaelle Gravis
Soazig Nénan-Le Ficher
Bastien Cabarrou
Thomas Filleron
Show All
Source
Cite
Save
Citations (2)
ALBAN: An open label, randomized, phase III trial, evaluating efficacy of atezolizumab in addition to one year BCG (bacillus Calmette-Guerin) bladder instillation in BCG-naive patients with high-risk nonmuscle invasive bladder cancer (AFU-GETUG 37).
2019
Journal of Clinical Oncology
Morgan Rouprêt
Yann Neuzillet
Aurélie Bertaut
Géraldine Pignot
Nadine Houede
Stéphane Champiat
Soazig Nénan-Le Ficher
Maggy Chausson
Yohann Loriot
Show All
Source
Cite
Save
Citations (3)
1